Top

04-11-2016 | Rheumatoid arthritis | Review | Article

Update on the genetic architecture of rheumatoid arthritis

Journal: Nature Reviews Rheumatology

Authors: Kwangwoo Kim, So-Young Bang, Hye-Soon Lee, Sang-Cheol Bae

Publisher: Nature Publishing Group UK

Abstract

Human genetic studies into rheumatoid arthritis (RA) have uncovered more than 100 genetic loci associated with susceptibility to RA and have refined the RA-association model for HLA variants. The majority of RA-risk variants are highly shared across multiple ancestral populations and are located in noncoding elements that might have allele-specific regulatory effects in relevant tissues. Emerging multi-omics data, high-density genotype data and bioinformatic approaches are enabling researchers to use RA-risk variants to identify functionally relevant cell types and biological pathways that are involved in impaired immune processes and disease phenotypes. This Review summarizes reported RA-risk loci and the latest insights from human genetic studies into RA pathogenesis, including how genetic data has helped to identify currently available drugs that could be repurposed for patients with RA and the role of genetics in guiding the development of new drugs.

Nat Rev Rheumatol 2017;13:13–24. doi:10.1038/nrrheum.2016.176

Aho, K., Koskenvuo, M., Tuominen, J. & Kaprio, J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J. Rheumatol. 13, 899–902 (1986).PubMed

Silman, A. J. et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 32, 903–907 (1993).PubMed

MacGregor, A. J. et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43, 30–37 (2000).PubMed

van der Woude, D. et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 60, 916–923 (2009).PubMed

Terao, C. et al. A twin study of rheumatoid arthritis in the Japanese population. Mod. Rheumatol. 26, 685–689 (2016).PubMed

Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).PubMed

Lenz, T. L. et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat. Genet. 47, 1085–1090 (2015).PubMedPubMedCentral

Stahl, E. A. et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44, 483–489 (2012).PubMedPubMedCentral

Horton, R. et al. Gene map of the extended human MHC. Nat. Rev. Genet. 5, 889–899 (2004).PubMed

10.

Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205–1213 (1987).PubMed

11.

Bang, S. Y., Lee, H. S., Lee, K. W. & Bae, S. C. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope. J. Rheumatol. 40, 1054–1062 (2013).PubMed

12.

Shimane, K. et al. An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes. Rheumatology (Oxford) 52, 1172–1182 (2013).

13.

Reynolds, R. J. et al. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol. 66, 3274–3282 (2014).PubMedPubMedCentral

14.

Lee, H. S. et al. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum. 50, 3468–3475 (2004).PubMed

15.

Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).PubMedPubMedCentral

16.

Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291–296 (2012).PubMedPubMedCentral

17.

Kim, K. et al. Imputing variants in HLA-DR beta genes reveals that HLA-DRB1 is solely associated with rheumatoid arthritis and systemic lupus erythematosus. PLoS ONE 11, e0150283 (2016).PubMedPubMedCentral

18.

Okada, Y. et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum. Mol. Genet. 23, 6916–6926 (2014).PubMedPubMedCentral

19.

Han, B. et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am. J. Hum. Genet. 94, 522–532 (2014).PubMedPubMedCentral

20.

Anderson, K. M. et al. A molecular analysis of the shared epitope hypothesis binding of arthritogenic peptides to DRB1*04 alleles. Arthritis Rheumatol. 68, 1627–1636 (2016).PubMed

21.

Hu, X. et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat. Genet. 47, 898–905 (2015).PubMedPubMedCentral

22.

Kim, K. et al. Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. Arthritis Rheumatol. 67, 2611–2623 (2015).PubMedPubMedCentral

23.

Kurreeman, F. et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am. J. Hum. Genet. 88, 57–69 (2011).PubMedPubMedCentral

24.

Terao, C. et al. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects. Ann. Rheum. Dis. 70, 2134–2139 (2011).PubMed

25.

Viatte, S. et al. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann. Rheum. Dis. 71, 1984–1990 (2012).PubMed

26.

Bossini-Castillo, L. et al. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann. Rheum. Dis. 74, e15 (2015).PubMed

27.

Wagner, C. A. et al. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles. Ann. Rheum. Dis. 74, 579–586 (2015).PubMed

28.

Kim, K. et al. High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann. Rheum. Dis. 74, e13 (2015).PubMed

29.

Cobb, J. E. et al. Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in Europeans. PLoS ONE 8, e66456 (2013).PubMedPubMedCentral

30.

McAllister, K. et al. Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data. Arthritis Rheum. 65, 3058–3062 (2013).PubMedPubMedCentral

31.

Orozco, G. et al. Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study. Arthritis Rheumatol. 66, 24–30 (2014).PubMed

32.

Okada, Y. et al. Significant impact of miRNA-target gene networks on genetics of human complex traits. Sci. Rep. 6, 22223 (2016).PubMedPubMedCentral

33.

Kim, K. et al. Association-heterogeneity mapping identifies and Asian-spcific association of the GTF2I locus with rheumatoid arthritis. Sci. Rep. 6, 27563 (2016).PubMedPubMedCentral

34.

Fortune, M. D. et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat. Genet. 47, 839–846 (2015).PubMedPubMedCentral

35.

Gusev, A. et al. Quantifying missing heritability at known GWAS loci. PLoS Genet. 9, e1003993 (2013).PubMedPubMedCentral

36.

Okada, Y. et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet. 44, 511–516 (2012).PubMed

37.

Kurreeman, F. A. et al. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12. Am. J. Hum. Genet. 90, 524–532 (2012).PubMedPubMedCentral

38.

Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337–343 (2015).PubMed

39.

Kichaev, G. & Pasaniuc, B. Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet. 97, 260–271 (2015).PubMedPubMedCentral

40.

Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013).PubMed

41.

Heintzman, N. D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311–318 (2007).PubMed

42.

Trynka, G. et al. Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complex-trait loci. Am. J. Hum. Genet. 97, 139–152 (2015).PubMedPubMedCentral

43.

Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461 (2014).PubMedPubMedCentral

44.

Freudenberg, J., Gregersen, P. & Li, W. Enrichment of genetic variants for rheumatoid arthritis within T-cell and NK-cell enhancer regions. Mol. Med. 21, 180–184 (2015).PubMedPubMedCentral

45.

Vahedi, G. et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520, 558–562 (2015).PubMedPubMedCentral

46.

Hrdlickova, B. et al. Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity. Genome Med. 6, 88 (2014).PubMedPubMedCentral

47.

Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).PubMedPubMedCentral

48.

Carpenter, S. et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 341, 789–792 (2013).PubMedPubMedCentral

49.

Hyatt, G. et al. Gene expression microarrays: glimpses of the immunological genome. Nat. Immunol. 7, 686–691 (2006).PubMed

50.

Hu, X. et al. Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am. J. Hum. Genet. 89, 496–506 (2011).PubMedPubMedCentral

51.

Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712 (1999).PubMed

52.

Raj, T. et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519–523 (2014).PubMedPubMedCentral

53.

Hu, X. et al. Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4⁺ effector memory T cells. PLoS Genet. 10, e1004404 (2014).PubMedPubMedCentral

54.

Smemo, S. et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371–375 (2014).PubMedPubMedCentral

55.

Stratigopoulos, G., LeDuc, C. A., Cremona, M. L., Chung, W. K. & Leibel, R. L. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J. Biol. Chem. 286, 2155–2170 (2011).PubMed

56.

Stratigopoulos, G. et al. Hypomorphism for RPGRIP1L, a ciliary gene vicinal to the FTO locus, causes increased adiposity in mice. Cell Metab. 19, 767–779 (2014).PubMedPubMedCentral

57.

Martin, P. et al. Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat. Commun. 6, 10069 (2015).PubMed

58.

Segre, A. V. et al. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 6, e1001058 (2010).PubMedPubMedCentral

59.

Eppig, J. T. et al. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 40, D881–D886 (2012).PubMed

60.

de Rooy, D. P. et al. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann. Rheum. Dis. 72, 769–775 (2013).PubMed

61.

Yarwood, A. et al. Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA. Genes Immun. 14, 325–329 (2013).PubMedPubMedCentral

62.

Liu, G. et al. Measles contributes to rheumatoid arthritis: evidence from pathway and network analyses of genome-wide association studies. PLoS ONE 8, e75951 (2013).PubMedPubMedCentral

63.

Andreassen, O. A. et al. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS ONE 10, e0123057 (2015).PubMedPubMedCentral

64.

Buchel, F. et al. Integrative pathway-based approach for genome-wide association studies: identification of new pathways for rheumatoid arthritis and type 1 diabetes. PLoS ONE 8, e78577 (2013).PubMedPubMedCentral

65.

Maggadottir, S. M. & Sullivan, K. E. The intersection of immune deficiency and autoimmunity. Curr. Opin. Rheumatol. 26, 570–578 (2014).PubMed

66.

Timmons, J. A., Szkop, K. J. & Gallagher, I. J. Multiple sources of bias confound functional enrichment analysis of global-omics data. Genome Biol. 16, 186 (2015).PubMedPubMedCentral

67.

Atzeni, F. et al. Different effects of biological drugs in rheumatoid arthritis. Autoimmun. Rev. 12, 575–579 (2013).PubMed

68.

Grover, M. P. et al. Identification of novel therapeutics for complex diseases from genome-wide association data. BMC Med. Genomics 7 (Suppl. 1), S8 (2014).PubMedPubMedCentral

69.

Maloney, D. G. et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90, 2188–2195 (1997).PubMed

70.

Edwards, J. C. et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572–2581 (2004).PubMed

71.

Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581–594 (2013).PubMed

72.

Li, G. et al. Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway. PLoS Genet. 9, e1003487 (2013).PubMedPubMedCentral

73.

Ekwall, A. K. et al. The rheumatoid arthritis risk gene LBH regulates growth in fibroblast-like synoviocytes. Arthritis Rheumatol. 67, 1193–1202 (2015).PubMedPubMedCentral

74.

Giles, J. L., Choy, E., van den Berg, C., Morgan, B. P. & Harris, C. L. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J. Immunol. 194, 3029–3034 (2015).PubMedPubMedCentral

75.

Schuster, C. et al. The autoimmunity-associated gene CLEC16A modulates thymic epithelial cell autophagy and alters T cell selection. Immunity 42, 942–952 (2015).PubMedPubMedCentral

76.

Chang, H. H., Dwivedi, N., Nicholas, A. P. & Ho, I. C. The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthritis Rheumatol. 67, 2323–2334 (2015).PubMed

77.

Spurlock, C. F. III, Tossberg, J. T., Olsen, N. J. & Aune, T. M. Cutting edge: chronic NF-κB activation in CD4⁺ T Cells in rheumatoid arthritis is genetically determined by HLA risk alleles. J. Immunol. 195, 791–795 (2015).PubMed

78.

Muthana, M. et al. C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 112, 11618–11623 (2015).PubMedPubMedCentral

79.

Messemaker, T. C. et al. A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels. Genes Immun. 17, 85–92 (2015).PubMed

80.

de la Puerta, M. L. et al. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling. PLoS ONE 8, e54569 (2013).PubMedPubMedCentral

81.

Han, T. U. et al. Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis. Arthritis Rheum. 65, 590–598 (2013).PubMed

82.

Ferreira, R. C. et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 9, e1003444 (2013).PubMedPubMedCentral

83.

Lewis, M. J. et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96, 221–234 (2015).PubMedPubMedCentral

84.

Suzuki, A. & Yamamoto, K. From genetics to functional insights into rheumatoid arthritis. Clin. Exp. Rheumatol. 33 (4 Suppl. 92), S40–S43 (2015).PubMed

85.

Viatte, S. et al. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA 313, 1645–1656 (2015).PubMedPubMedCentral

86.

Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era — concepts and misconceptions. Nat. Rev. Genet. 9, 255–266 (2008).PubMed

87.

Svendsen, A. J. et al. On the origin of rheumatoid arthritis: the impact of environment and genes — a population based twin study. PLoS ONE 8, e57304 (2013).PubMedPubMedCentral

88.

Diogo, D. et al. Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. Am. J. Hum. Genet. 92, 15–27 (2013).PubMedPubMedCentral

89.

Diogo, D. et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS ONE 10, e0122271 (2015).PubMedPubMedCentral

90.

Bang, S. Y. et al. Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis. Arthritis Res. Ther. 16, 447 (2014).PubMedPubMedCentral

91.

Okada, Y. et al. Integration of sequence data from a consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene. PLoS ONE 9, e87645 (2014).PubMedPubMedCentral

92.

Veal, C. D. et al. A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3. Hum. Mutat. 35, 248–256 (2014).PubMed

93.

Du, Y. et al. Contribution of functional LILRA3, but not nonfunctional LILRA3, to sex bias in susceptibility and severity of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 66, 822–830 (2014).PubMed

94.

Chen, J. Y. et al. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients. Arthritis Rheumatol. 66, 3113–3121 (2014).PubMedPubMedCentral

95.

Franke, L. et al. Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes. Eur. J. Hum. Genet. 24, 263–270 (2016).PubMed

96.

Wu, C. C. et al. Whole-genome detection of disease-associated deletions or excess homozygosity in a case–control study of rheumatoid arthritis. Hum. Mol. Genet. 22, 1249–1261 (2013).PubMed

97.

Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).PubMedPubMedCentral

Medicine Matters Rheumatology

Abstract